Skip to main content

ProShare Advisors LLC

Position in NRIX — Nurix Therapeutics, Inc.

CIK 1357955 BETHESDA, MD

Position in NRIX

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$386,728
+$86,943 QoQ
Shares Held
15,941
-17.6% QoQ
Ownership
0.015%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#141
of 210 holders
Holding Since
Dec 2020
17 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NRIX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ProShare Advisors LLC holds $336,334,656 across 174 Biotechnology names. NRIX ranks #65 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in NRIX

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $386,728 15,941
2026-03-31 $299,785 19,341
2025-12-31 $432,402 22,794
2025-09-30 $144,273 15,614
2025-06-30 $208,493 18,305
2025-03-31 $234,107 19,706
2024-12-31 $435,806 23,132
2024-09-30 $356,621 15,871
2024-06-30 $209,472 10,037
2024-03-31 $176,076 11,978
2023-12-31 $113,313 10,980
2022-03-31 $146,950 10,489
2021-12-31 $380,055 13,128
2021-09-30 $404,609 13,505
2021-06-30 $426,973 16,094
2021-03-31 $367,763 11,829
2020-12-31 $282,110 8,580